Human Bone Marrow Mesenchymal Stem Cell (hBMSCs)-Derived miR-29a-3p-Containing Exosomes Impede Laryngocarcinoma Cell Malignant Phenotypes by Inhibiting PTEN

Figure 1

The relationship between miR-29a-3p and PTEN in laryngocarcinoma. (a–b) QRT-PCR analysis of miR-29a-3p in laryngocarcinoma tissues (a) and cancer cell lines (b). (c–d) QRT-PCR analysis of PTEN in laryngocarcinoma tissues (c) and cancer cell lines (d). (e) Correlation analysis between miR-29a-3p and PTEN level in laryngocarcinoma tissues. (f) Base sequence of miR-29a-3p and the wild-type as well as the mutant PTEN 3UTR by Targetscan. (g) Luciferase activity detection after transfection in M4E cells. (h) The enrichment analysis of miR-29a-3p in M4E cells using biotin labelled PTEN probe. (i) QRT-PCR analysis of PTEN in M4E cells after transfected with miR mimics. , , and .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)